# The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD

> **NCT00274222** · — · TERMINATED · sponsor: **Inonu University** · enrollment: 120 (—)

## Conditions studied

- COPD Acute Exacerbation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00274222
- **Lead sponsor:** Inonu University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 120 (—)
- **Last updated:** 2006-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274222, "The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00274222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
